Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Evaluation of Selected CYP51A1 Polymorphisms in View of Interactions with Substrate and Redox Partner.

Režen T, Ogris I, Sever M, Merzel F, Golic Grdadolnik S, Rozman D.

Front Pharmacol. 2017 Jun 30;8:417. doi: 10.3389/fphar.2017.00417. eCollection 2017.

2.

Rosuvastatin and Atorvastatin Are Ligands of the Human Constitutive Androstane Receptor/Retinoid X Receptor α Complex.

Režen T, Hafner M, Kortagere S, Ekins S, Hodnik V, Rozman D.

Drug Metab Dispos. 2017 Aug;45(8):974-976. doi: 10.1124/dmd.117.075523. Epub 2017 May 23.

PMID:
28536098
3.

Response to the letter to the editor by Kristensen MM, Helge JW and Dela F.

Režen T, Kovanda A, Eiken O, Mekjavič I, Rogelj B.

Acta Physiol (Oxf). 2015 Oct;215(2):76-8. doi: 10.1111/apha.12551. Epub 2015 Jul 31. No abstract available.

PMID:
26198423
4.

MicroRNA in skeletal muscle development, growth, atrophy, and disease.

Kovanda A, Režen T, Rogelj B.

Wiley Interdiscip Rev RNA. 2014 Jul-Aug;5(4):509-25. doi: 10.1002/wrna.1227. Epub 2014 May 16. Review.

PMID:
24838768
5.

Expression changes in human skeletal muscle miRNAs following 10 days of bed rest in young healthy males.

Režen T, Kovanda A, Eiken O, Mekjavic IB, Rogelj B.

Acta Physiol (Oxf). 2014 Mar;210(3):655-66. doi: 10.1111/apha.12228. Erratum in: Acta Physiol (Oxf). 2015 Nov;215(3):123-4.

PMID:
24410893
6.

The human primary hepatocyte transcriptome reveals novel insights into atorvastatin and rosuvastatin action.

Hafner M, Juvan P, Rezen T, Monostory K, Pascussi JM, Rozman D.

Pharmacogenet Genomics. 2011 Nov;21(11):741-50. doi: 10.1097/FPC.0b013e32834a5585.

PMID:
21869732
7.

Acrolein-induced dyslipidemia and acute-phase response are independent of HMG-CoA reductase.

Conklin DJ, Prough RA, Juvan P, Rezen T, Rozman D, Haberzettl P, Srivastava S, Bhatnagar A.

Mol Nutr Food Res. 2011 Sep;55(9):1411-22. doi: 10.1002/mnfr.201100225. Epub 2011 Aug 3.

8.

Regulation of hepatic cytochromes p450 by lipids and cholesterol.

Hafner M, Rezen T, Rozman D.

Curr Drug Metab. 2011 Feb;12(2):173-85. Review.

PMID:
21395540
9.

The impact of cholesterol and its metabolites on drug metabolism.

Režen T.

Expert Opin Drug Metab Toxicol. 2011 Apr;7(4):387-98. doi: 10.1517/17425255.2011.558083. Epub 2011 Feb 15. Review.

PMID:
21320036
10.

Obesity resistant mechanisms in the Lean polygenic mouse model as indicated by liver transcriptome and expression of selected genes in skeletal muscle.

Simončič M, Režen T, Juvan P, Rozman D, Fazarinc G, Fievet C, Staels B, Horvat S.

BMC Genomics. 2011 Feb 3;12:96. doi: 10.1186/1471-2164-12-96.

11.

Interplay between cholesterol and drug metabolism.

Rezen T, Rozman D, Pascussi JM, Monostory K.

Biochim Biophys Acta. 2011 Jan;1814(1):146-60. doi: 10.1016/j.bbapap.2010.05.014. Epub 2010 Jun 4. Review.

PMID:
20570756
12.

Acrolein consumption induces systemic dyslipidemia and lipoprotein modification.

Conklin DJ, Barski OA, Lesgards JF, Juvan P, Rezen T, Rozman D, Prough RA, Vladykovskaya E, Liu S, Srivastava S, Bhatnagar A.

Toxicol Appl Pharmacol. 2010 Feb 15;243(1):1-12. doi: 10.1016/j.taap.2009.12.010. Epub 2009 Dec 23.

13.

Effect of CAR activation on selected metabolic pathways in normal and hyperlipidemic mouse livers.

Rezen T, Tamasi V, Lövgren-Sandblom A, Björkhem I, Meyer UA, Rozman D.

BMC Genomics. 2009 Aug 19;10:384. doi: 10.1186/1471-2164-10-384.

14.

The Sterolgene v0 cDNA microarray: a systemic approach to studies of cholesterol homeostasis and drug metabolism.

Rezen T, Juvan P, Fon Tacer K, Kuzman D, Roth A, Pompon D, Aggerbeck LP, Meyer UA, Rozman D.

BMC Genomics. 2008 Feb 11;9:76. doi: 10.1186/1471-2164-9-76.

15.

Functional genomics approaches to studies of the cytochrome p450 superfamily.

Rezen T, Contreras JA, Rozman D.

Drug Metab Rev. 2007;39(2-3):389-99. Review.

PMID:
17786628
16.

Cholesterogenic lanosterol 14alpha-demethylase (CYP51) is an immediate early response gene.

Fink M, Acimovic J, Rezen T, Tansek N, Rozman D.

Endocrinology. 2005 Dec;146(12):5321-31. Epub 2005 Aug 25.

PMID:
16123160
17.

Supplemental Content

Support Center